Contact
Please use this form to send email to PR contact of this press release:
New KEYTRUDA® (pembrolizumab) Data Accepted for Presentation at SITC 2016 Annual Meeting
TO:
Please use this form to send email to PR contact of this press release:
New KEYTRUDA® (pembrolizumab) Data Accepted for Presentation at SITC 2016 Annual Meeting
TO: